Mubadala co-invests in UCB's mature business in China

Mubadala Investment Company announced today that in partnership with CBC Group, Asia's largest healthcare-dedicated asset management group, it has acquired 100% ownership in the carve-out of UCB Pharma’s mature business in China.UCB, a global biopharmaceutical company headquartered in Belgium, occupies a...